Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Pharmaceuticals Regulatory News (HEMO)

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
722.00    -2.00 (-0.28%)
Bid:
721.00
Ask:
769.00
Spread: 48.00 (6.657%)
Market Cap: £49.10m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Statement re: media speculation

7 Dec 2015 17:36

RNS Number : 2747I
Silver Falcon PLC
07 December 2015
 

7 December 2015

SILVER FALCON PLC

("Silver Falcon" or the "Company")

 

Statement regarding media speculation and share price movement

Silver Falcon PLC (LSE: SILF), the Main Board listed special purpose acquisition company set up to acquire businesses in the FinTech space, notes recent press speculation and movements in its share price.

The Company notes that a number of material pieces of information in recent press speculation are factually incorrect and should not be relied upon.

Whilst the Company has had initial discussions with a possible target concerning a possible transaction, all such discussions are at a preliminary stage. No exclusivity agreement or other binding, or non-binding agreements have been entered into with any party, and there is no certainty that any such agreements will be made. A further announcement will be made in due course.

 

 

For further information please contact:

Camarco Tel: +44 (0) 20 3757 4980

Jennifer Renwick / Billy Clegg / Zoё Moulton

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGGGWPUPAGMM
Date   Source Headline
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
18th Nov 20202:06 pmRNSSecond Price Monitoring Extn
18th Nov 20202:01 pmRNSPrice Monitoring Extension
18th Nov 202010:39 amRNSFinancing Facility of up to £60 Million
27th Oct 20207:00 amRNSCDX Development Agreement Further Extension
19th Oct 20207:00 amRNSPresentation at the American Society of Hematology
6th Oct 20207:00 amRNSSAFE-HEMO-CAR-T Effective against AML in vitro
30th Sep 20207:00 amRNSInterim Results for the period ended 30 June 2020
22nd Sep 202012:52 pmRNSFurther re. Grant of Options
10th Sep 20204:40 pmRNSSecond Price Monitoring Extn
10th Sep 20204:35 pmRNSPrice Monitoring Extension
26th Aug 20202:06 pmRNSSecond Price Monitoring Extn
26th Aug 20202:00 pmRNSPrice Monitoring Extension
25th Aug 20204:40 pmRNSSecond Price Monitoring Extn
25th Aug 20204:35 pmRNSPrice Monitoring Extension
21st Aug 20209:52 amRNSGrant of Options
14th Aug 20207:00 amRNSPresentations at Cancer Immunotherapy Symposia
11th Aug 20207:00 amRNSCAR-T Agreement with University of Pennsylvania
31st Jul 20207:00 amRNSBroker's Research Note
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
20th Jul 20202:05 pmRNSSecond Price Monitoring Extn
20th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20209:06 amRNSSecond Price Monitoring Extn
14th Jul 20209:00 amRNSPrice Monitoring Extension
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:16 pmRNSGrant of Options
13th Jul 20203:13 pmRNSFurther re Development Agreement
10th Jul 20201:00 pmRNSUS Subsidiary Change of Name
6th Jul 20207:00 amRNSNew Corporate Video and Investor Webinar
1st Jul 202012:58 pmRNSTotal Voting Rights
30th Jun 20204:40 pmRNSSecond Price Monitoring Extn
30th Jun 20204:35 pmRNSPrice Monitoring Extension
30th Jun 20202:06 pmRNSSecond Price Monitoring Extn
30th Jun 20202:00 pmRNSPrice Monitoring Extension
30th Jun 202010:30 amRNSDirector/PDMR Shareholding
26th Jun 20202:06 pmRNSSecond Price Monitoring Extn
26th Jun 20202:00 pmRNSPrice Monitoring Extension
26th Jun 202011:05 amRNSSecond Price Monitoring Extn
26th Jun 202011:00 amRNSPrice Monitoring Extension
26th Jun 20209:05 amRNSSecond Price Monitoring Extn
26th Jun 20209:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSDevelopment Agmnt - Autoimmune Disease Treatments
24th Jun 20207:00 amRNSHemogenyx Chairman Receives Tang Prize
19th Jun 20202:06 pmRNSSecond Price Monitoring Extn
19th Jun 20202:01 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSCOVID-19 Project Update
9th Jun 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.